Loading clinical trials...
Loading clinical trials...
This study investiagates deep-regional or superficial hyperthermia to enhance radiotherapy or chemoradiation in patients that suffer recurrent disease after previous radiotherapy.
patients that present a relapse within the previously irradiated volume can be included in this trial. These patients will receive re-irradiation according to clinical guidelines and hyperthermia as study intervention. According to tumor location hyperthermia can either be performed by microwave or by capacitive devices. The primary endpoint of this study is non-inferiority of re-irradiation compared to the initial course of radiotherapy (calculated as time to local failure).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Klinik für Radioonkologie und Strahlentherapie
Berlin, Germany
Start Date
May 10, 2024
Primary Completion Date
January 1, 2026
Completion Date
January 1, 2028
Last Updated
December 26, 2023
110
ESTIMATED participants
loco-regional hyperthermia
DEVICE
Lead Sponsor
Charite University, Berlin, Germany
NCT05691465
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions